Lista de obras -

"Heart without smoke" educational campaign - the role of patient education in secondary prevention of cardiovascular disease

artículo científico publicado en 2017

A 47‑year‑old woman with multifocal fibroelastoma and coronary artery disease

artículo científico publicado en 2019

Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension.

artículo científico publicado en 2018

Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry

artículo científico publicado en 2021

Apical pseudoaneurysm after transapical transcatheter aortic valve implantation

artículo científico publicado en 2017

Assessment of the implementation level of the guidelines for secondary prevention of cardiovascular disease in everyday clinical practice

artículo científico publicado en 2021

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

artículo científico publicado en 2017

Cardiac magnetic resonance imaging in a woman suspected of hypertrophic cardiomyopathy based on genotyping

scientific article published on 27 September 2018

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry

artículo científico publicado en 2021

Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty

artículo científico publicado en 2009

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.

artículo científico publicado en 2017

Exercise stress test methodology and safety in hypertrophic cardiomyopathy

artículo científico publicado en 2020

From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis

artículo científico publicado en 2020

Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP

artículo científico publicado en 2019

Knowledge and prevalence of risk factors for coronary artery disease in patients after the first and repeated percutaneous coronary intervention

scientific article published on 25 November 2019

Letter by Rajtar-Salwa and Dimitrow Regarding Article, "Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart"

scientific article published on 01 July 2018

Non-invasive cardiac imaging methods in transthyretin amyloidosis

artículo científico publicado en 2019

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

artículo científico publicado en 2016

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy.

artículo científico publicado en 2018

Pharmacotherapy of Aortic Stenosis-Success or Failure?

artículo científico publicado el 1 de octubre de 2012

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function - advanced diagnosis and therapy in heart failure

artículo científico publicado en 2017

Predictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosis

artículo científico publicado en 2013

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes

artículo científico publicado en 2019

Release of troponin after exercise stress test in hypertrophic cardiomyopathy

scientific article published on 10 July 2020

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy

artículo científico publicado en 2020

Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study

scientific article published on 01 March 2020

Reversing the poor prognosis of primary light-chain amyloidosis with cardiac involvement

artículo científico publicado en 2022

Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy

artículo científico publicado en 2016

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy

artículo científico publicado en 2020

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry

The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy

artículo científico publicado en 2017

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry

artículo científico publicado en 2020

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).

artículo científico publicado en 2017

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry

artículo científico publicado en 2021

Lista de obras de

"Heart without smoke" educational campaign - the role of patient education in secondary prevention of cardiovascular disease

A 47‑year‑old woman with multifocal fibroelastoma and coronary artery disease

Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension.

Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines-data from the POLish Atrial Fibrillation (POL-AF) Registry

Apical pseudoaneurysm after transapical transcatheter aortic valve implantation

Assessment of the implementation level of the guidelines for secondary prevention of cardiovascular disease in everyday clinical practice

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

Cardiac magnetic resonance imaging in a woman suspected of hypertrophic cardiomyopathy based on genotyping

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry

Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.

Exercise stress test methodology and safety in hypertrophic cardiomyopathy

From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis

Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP

Knowledge and prevalence of risk factors for coronary artery disease in patients after the first and repeated percutaneous coronary intervention

Letter by Rajtar-Salwa and Dimitrow Regarding Article, "Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart"

Non-invasive cardiac imaging methods in transthyretin amyloidosis

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy.

Pharmacotherapy of Aortic Stenosis-Success or Failure?

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function - advanced diagnosis and therapy in heart failure

Predictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosis

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes

Release of troponin after exercise stress test in hypertrophic cardiomyopathy

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy

Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study

Reversing the poor prognosis of primary light-chain amyloidosis with cardiac involvement

Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry

The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry